CurveBeam AI (ASX:CVB) Current Accrued Expense : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Current Accrued Expense?

CurveBeam AI's Current Accrued Expense for the quarter that ended in Dec. 2023 was A$0.00 Mil.

CurveBeam AI Current Accrued Expense Historical Data

The historical data trend for CurveBeam AI's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Current Accrued Expense Chart

CurveBeam AI Annual Data

Trend

Jun21

Jun22

Jun23

Current Accrued Expense

CurveBeam AI Semi-Annual Data
	Jun21	Dec21	Jun22	Jun23	Dec23
Current Accrued Expense	-	-	-	-	-

CurveBeam AI Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

CurveBeam AI Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CurveBeam AI (ASX:CVB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.curvebeamai.com

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines